These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7105380)
1. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities. Hill BT; Whelan RD Cancer Chemother Pharmacol; 1982; 8(2):163-9. PubMed ID: 7105380 [TBL] [Abstract][Full Text] [Related]
2. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine. Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658 [TBL] [Abstract][Full Text] [Related]
3. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266 [TBL] [Abstract][Full Text] [Related]
4. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines. Hill BT; Whelan RD J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380 [TBL] [Abstract][Full Text] [Related]
5. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine. Conter V; Beck WT Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648 [TBL] [Abstract][Full Text] [Related]
6. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids. Poppitt DG; McGown AT; Fox BW Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841 [TBL] [Abstract][Full Text] [Related]
7. Vindesine: a new vinca alkaloid. Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine. Sone S; Ishii K; Tsuruo T Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026 [TBL] [Abstract][Full Text] [Related]
9. Establishment and properties of vincristine-resistant human myelogenous leukemia K562. Tsuruo T; Iida H; Ohkochi E; Tsukagoshi S; Sakurai Y Gan; 1983 Oct; 74(5):751-8. PubMed ID: 6580255 [TBL] [Abstract][Full Text] [Related]
10. Acquired vs innate multidrug resistance and the effect of calcium channel blockers. Tsuruo T Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. Photiou A; Sheikh MN; Bafaloukos D; Retsas S J Cancer Res Clin Oncol; 1992; 118(4):249-54. PubMed ID: 1577845 [TBL] [Abstract][Full Text] [Related]
12. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents. Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348 [TBL] [Abstract][Full Text] [Related]
13. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro. Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro. Hill BT; Hosking LK; Shellard SA; Whelan RD Cancer Chemother Pharmacol; 1989; 23(3):140-4. PubMed ID: 2924371 [TBL] [Abstract][Full Text] [Related]
15. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis. McGown AT; Poppitt DG; Swindell R; Fox BW Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842 [TBL] [Abstract][Full Text] [Related]
16. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells. Ohi Y; Kim R; Toge T Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632 [TBL] [Abstract][Full Text] [Related]
17. Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro. Hill BT Drugs Exp Clin Res; 1986; 12(1-3):293-8. PubMed ID: 3732052 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro. Hill BT; Whelan RD Cancer Treat Rev; 1980 Sep; 7 Suppl 1():5-15. PubMed ID: 6159973 [No Abstract] [Full Text] [Related]
19. Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates. Conrad RA; Cullinan GJ; Gerzon K; Poore GA J Med Chem; 1979 Apr; 22(4):391-400. PubMed ID: 430477 [TBL] [Abstract][Full Text] [Related]
20. Correlates of vincristine resistance in four murine tumor cell lines. Bender RA; Kornreich WD; Wodinsky I Cancer Lett; 1982; 15(3):335-41. PubMed ID: 7116335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]